-
Casirivimab/imdevimab, sold
under the
brand name REGEN‑COV
among others, is a
combination medicine used for the
treatment and
prevention of COVID‑19....
- 2020, the
monoclonal antibody therapies bamlanivimab/etesevimab and
casirivimab/imdevimab were
given emergency use
authorizations by the US Food and...
- the
public domain. "
Casirivimab injection, solution,
concentrate Imdevimab injection, solution,
concentrate REGEN-COV –
casirivimab and
imdevimab kit"...
- 28
October 2020. "
Casirivimab injection, solution,
concentrate Imdevimab injection, solution,
concentrate REGEN-COV-
casirivimab and
imdevimab kit"....
-
antibody treatments – bamlanivimab/etesevimab (administered together) and
casirivimab/imdevimab – to
limit their use to only when the
recipients are likely...
- Bebtelovimab§
Casirivimab† (+imdevimab) Cilgavimab† (+tixagevimab)† Diridavumab§ Etesevimab† Exbivirumab§ Foravirumab§ Imdevimab† (+
casirivimab) Libivirumab§...
- 2021, the
monoclonal antibody therapies bamlanivimab/etesevimab and
casirivimab/imdevimab were
found to
reduce the
number of hospitalizations, emergency...
-
cilgavimab J06BD04
Ansuvimab J06BD05
Sotrovimab J06BD06
Regdanvimab J06BD07
Casirivimab and
imdevimab J06BD08
Nirsevimab Immune sera and
immunoglobulins for...
-
against use of
plasma in COVID-19 in
December 2021.
Monoclonal antibodies (
casirivimab/imdevimab) were
developed for the
treatment of COVID-19. On June 7, 2021...
-
carvotroline (INN)
Carvykti carzelesin (INN)
carzenide (INN)
Casgevy casimersen casirivimab and
imdevimab Casodex casokefamide (INN)
casopitant (USAN, INN) caspofungin...
